Ready to Talk
Colorado?

Contact Our Economic Development and Relocation Experts.

"*" indicates required fields

The information submitted through this form will be used by Colorado BioScience Association (CBSA) and Metro Denver Economic Corporation (MDEDC) for the purpose of evaluating and facilitating economic development opportunities. It will be handled with the utmost confidentiality and will not be disclosed to third parties without explicit consent.

Leader Partner

AGC Biologics

Founding Partner

AGC Biologics is a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO) with a strong commitment to delivering the highest standard of service as we work side-by-side with our clients and partners, every step of the way. We provide world-class development and manufacture of mammalian and microbial-based therapeutic proteins, plasmid DNA (pDNA), messenger RNA (mRNA), viral vectors, and genetically engineered cells. Our global network spans the U.S., Europe, and Asia, with cGMP-compliant facilities in Seattle, Washington; Boulder and Longmont, Colorado; Copenhagen, Denmark; Heidelberg, Germany; Milan, Italy; and Chiba, Japan and we currently employ more than 2,500 employees worldwide. Our commitment to continuous innovation fosters the technical creativity to solve our clients’ most complex challenges, including specialization in fast-track projects and rare diseases. AGC Biologics is the partner of choice.

AGC Biologics

Michael Tranmer

Senior Vice President and General Manager, Boulder Facility

Michael Tranmer

Michael Tranmer joined AGC Biologics in July 2023. Michael has over 30 years of experience in the pharmaceutical, biological, and medical device industries. His career started in animal health vaccine research before he moved into mammalian cell production. Since then, his experience has spanned both management and executive roles with increasing responsibility in manufacturing operations, with companies such as Pfizer, SmithKline Beecham, Endo/Par, Mesa Labs, and Strides Pharma Inc. Michael has a successful track record of delivering against expectations regarding safety, regulatory compliance, financial, and operational objectives. He has built strong leadership teams and has been a culture change agent throughout his career.

Michael Tranmer
teal circle background icon

At AGC Biologics, we are committed to bringing hope to life by enabling life-changing therapies for patients around the globe. Our facilities in Colorado, along with our global network, provide a dynamic environment for our team members to deliver that purpose, as we provide friendly and expert CDMO services to our customers.

Michael Tranmer

magenta circle background icon
Meet AGC Biologics

Partner News and Insights

AGC Biologics' Success Highlights Colorado's Appeal for Life Sciences Companies

AGC Biologics’ Success Highlights Colorado’s Appeal for Life Sciences Companies

AGC Biologics, a global CDMO, operates two major facilities in Colorado. After investing in its Boulder facility in 2020 with support from the state of Colorado and regional economic development groups, the company acquired its Longmont facility in 2021. The recent expansion of AGC Biologics’ Longmont facility enhances the region’s appeal for life sciences companies. Three new Grade B cell therapy suites, featuring cutting-edge modular clean room design and flexible capacity configuration, strengthens the Longmont site’s cell therapy capabilities. This enhancement complements the existing viral vector expansion completed in 2022, which included a range of bioreactor sizes for product development (AMBR, 10L and 50L), and a complete range of commercial manufacturing capacities (50L, 200L, 500L and 2000L), enabling the site to provide support for the entire lifecycle of a product.

The expansion enables AGC Biologics to provide end-to-end cell therapy development and manufacturing services in one location, offering unique benefits to developers seeking comprehensive support for bringing their products to market. With additional space available, AGC Biologics is well-prepared to further expand its cell therapy capabilities to meet the growing market demand. This expansion reinforces Colorado’s position a leading hub for cutting-edge biotech innovation and commercialization.

Click here for the full article.

Let us know!

Ready to Talk
Colorado?

Contact Our Economic Development and Relocation Experts.

The information submitted through this form will be used by Colorado BioScience Association (CBSA) and Metro Denver Economic Corporation (MDEDC) for the purpose of evaluating and facilitating economic development opportunities. It will be handled with the utmost confidentiality and will not be disclosed to third parties without explicit consent.

"*" indicates required fields

Large magenta CO text
Meet Our Partners

Colorado:
Hub for Health Impact

We love to collaborate with new arrivals. Our welcoming life sciences community is right-sized for high-growth companies. There’s more than a million square feet of lab space planned or in development critical infrastructure and state support for startups expansions and relocations. Our supportive partners are ready for every step of the journey.